Related Experiment Videos
Influence of foscarnet on HIV-associated Kaposi's sarcoma derived cell lines
C P Willers1, G Reimann, L Mertins
1Ruhr-University Bochum, St. Josef-Hospital, Gudrunstr. 56, D-44791 Bochum, Germany.
Abstract:
Recent reports showed a positive therapeutic effect of foscarnet on Kaposi's sarcoma (KS) in HIV-positive patients. We investigated the therapeutic effect of foscarnet on KS-derived cell lines. Three KS spindle cell cultures of HIV-positive patients as well three fibroblast cell cultures of HIV-positive as HIV-negative patients were established. The influence of different foscarnet concentrations (50, 100, 200, 400, 600, 1000 microg/ml) on these cell lines were analysed. There was no significant change in fibroblast cell numbers suggesting that there is neither a proliferative nor an antiproliferative effect of foscarnet on these cell lines. Furthermore, incubation of the three KS-derived cell lines of HIV-positive patients with different foscarnet concentrations did not change KS-cell number significantly.
Insights
Foscarnet did not demonstrate therapeutic effects on Kaposi
Area of Science:
- Oncology
- Virology
- Pharmacology
Background:
- Kaposi's sarcoma (KS) is an opportunistic malignancy frequently affecting HIV-positive individuals.
- Previous reports suggested a potential therapeutic benefit of foscarnet in treating Kaposi's sarcoma.
Purpose of the Study:
- To investigate the in vitro therapeutic efficacy of foscarnet on Kaposi's sarcoma-derived cell lines.
- To assess the effect of foscarnet on both KS spindle cells and fibroblast cell lines from HIV-positive and HIV-negative patients.
Main Methods:
- Establishment of three KS spindle cell cultures and three fibroblast cell cultures from HIV-positive and HIV-negative patients.
- Exposure of cell lines to varying concentrations of foscarnet (50–1000 microg/ml).
- Analysis of cell numbers to determine proliferative or antiproliferative effects.
Main Results:
- Foscarnet exhibited no significant impact on the proliferation or number of fibroblast cell lines.
- Incubation with foscarnet at different concentrations did not significantly alter the cell number of KS-derived cell lines.
- No significant antiproliferative or proliferative effects were observed in either KS or fibroblast cells.
Conclusions:
- Foscarnet does not appear to possess direct anti-KS activity in vitro.
- The study findings do not support the previous reports of foscarnet's therapeutic effect on Kaposi's sarcoma.
- Further research may be needed to explore other potential mechanisms or drug combinations.